CMPX

CMPX Operating Expenses

$80.35MTTM · USD

Period ending:

CMPX FY Operating ExpensesUSD
CMPX FY Operating Expenses2019-03-31: $38.31M2020-03-31: $34.05M2020-12-31: $27.81M2021-12-31: $81.88M2022-12-31: $41.66M2023-12-31: $50.36M2024-12-31: $57.48M2025-12-31: $71.37M$81.88M$0.00
2019-03-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

CMPX operating expenses history

Expenses from normal business operations (SG&A, R&D, etc.). The available annual fiscal periods series contains 8 observations from Mar 31, 2019 to Dec 31, 2025.

Compass Therapeutics Operating Expenses — Annual fiscal periods (USD)
Period endingOperating Expenses (USD)
71,367,000
57,475,000
50,363,000
41,655,000
81,882,000
27,812,000
34,052,000
38,312,000

Compare operating expenses

All CMPX financial metrics · CMPX stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.